A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells.
about
Frizzled7: A Promising Achilles' Heel for Targeting the Wnt Receptor Complex to Treat CancerRole of MicroRNAs-221/222 in Digestive SystemsColorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management.Transcriptomic and proteomic analyses reveal key innate immune signatures in the host response to the gastrointestinal pathogen Campylobacter concisusMicroRNA-221 promotes human non-small cell lung cancer cell H460 growth.MicroRNA-217 functions as a prognosis predictor and inhibits colorectal cancer cell proliferation and invasion via an AEG-1 dependent mechanism.An update on miRNAs as biological and clinical determinants in colorectal cancer: a bench-to-bedside approach.IFN-α-Induced Downregulation of miR-221 in Dendritic Cells: Implications for HCV Pathogenesis and Treatment.MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway.Transgenic Expression of miR-222 Disrupts Intestinal Epithelial Regeneration by Targeting Multiple Genes Including Frizzled-7.miRNA profiling of circulating EpCAM(+) extracellular vesicles: promising biomarkers of colorectal cancer.miR-221 promotes growth and invasion of hepatocellular carcinoma cells by constitutive activation of NFκB.RelB/NF-κB links cell cycle transition and apoptosis to endometrioid adenocarcinoma tumorigenesis.Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases.MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications.Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer.The microRNA regulatory network: a far-reaching approach to the regulate the Wnt signaling pathway in number of diseases.MicroRNAs as biomarkers and prospective therapeutic targets in colon and pancreatic cancers.Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p.MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.Posttranscriptional regulation of intestinal epithelial integrity by noncoding RNAs.MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer.MicroRNAs at the epicenter of intestinal homeostasis.Regulatory miRNAs in Colorectal Carcinogenesis and Metastasis.MicroRNA-222 influences migration and invasion through MIA3 in colorectal cancerMiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTENIdentification of a novel substance P (SP)-neurokinin-1 receptor (NK-1R) microRNA-221-5p inflammatory network in human colonic epithelial cells.MicroRNA-133a-3p exerts inhibitory effects on gallbladder carcinoma via targeting RBPJ.Roles of microRNAs and RNA-Binding Proteins in the Regulation of Colorectal Cancer Stem Cells.Regulation of CD4 Receptor and HIV-1 Entry by MicroRNAs-221 and -222 during Differentiation of THP-1 Cells.The relationship between microRNAs and the STAT3-related signaling pathway in cancer.Fish Oil Contaminated with Persistent Organic Pollutants Induces Colonic Aberrant Crypt Foci Formation and Reduces Antioxidant Enzyme Gene Expression in Rats.miR-222 isoforms are differentially regulated by type-I interferon.Modified Polyadenylation-Based RT-qPCR Increases Selectivity of Amplification of 3'-MicroRNA Isoforms.Targeting the IL-6/JAK/STAT3 signalling axis in cancer.MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1.Effects of moderate alcohol consumption on gene expression related to colonic inflammation and antioxidant enzymes in rats.What Makes the Harderian Gland Transcriptome Different From Other Chicken Immune Tissues? A Gene Expression Comparative Analysis.PIAS3-mediated feedback loops promote chronic colitis-associated malignant transformation.Screening and surveillance methods for dysplasia in inflammatory bowel disease patients: Where do we stand?
P2860
Q26747651-D98D24E2-ED32-43FB-9763-A0D6206F3D9CQ26799877-0DF36A56-5AF4-4613-B541-6550F5DC388CQ30245054-F8962457-6390-4FFE-941F-29E76F56F641Q34955777-BEAAA5FA-497C-4C96-A22B-8514FD19F3F3Q35479794-47B149D5-F0B9-4F4C-905E-7EC740DD5424Q35643217-E414567B-9097-4648-9411-302AA84C9121Q35811250-DFC9744D-09D5-4DF9-8F52-2D05CC3878EEQ36030286-F5794373-FC0A-4572-8631-0CA6628603FCQ36189343-3015D983-CF1A-4F3D-9873-E4FBDE8248FFQ36568272-CC0E2B72-6BFD-4B88-A86E-A4929E4B9613Q37218300-DD21265E-AA9F-48B3-A31B-1AB054A3A5A5Q37448131-E27C21BF-F4F2-46E3-B319-6A726602035AQ37465878-2ACB267B-38BB-45C3-9244-89AD0CED1CBCQ37643929-35F556DF-93C6-4680-BE75-5E81819F8B55Q37731180-7978147F-C675-4978-A3CE-D7D9A490F9D5Q38369000-C235625D-EFA0-45AF-B3DD-48D54834A5FDQ38622178-84F11A56-EF40-447B-8A46-474451E120CFQ38625447-183F7DFD-FA74-453F-B9DD-A36A41AD278BQ38661866-D6AABFA5-60EA-494D-A2BF-74B163AAF3E1Q38839158-7080CB1F-824C-4DDC-B245-79BC90EA51F9Q38972646-30CA3EF8-0D06-4508-8F6A-60022B046415Q39090370-B4FA2738-0606-47BA-A716-A8DAA802C32DQ39117431-615B92F7-F39D-45FC-99E1-0834401266CCQ39261789-A4CF544B-F32A-443E-B7D3-9BC2EAEC9C3FQ41558190-2D4FFFA0-91FA-408F-979F-98C2B903C672Q41890736-0D7E76AC-8522-466C-B5B0-9439286DDFAAQ42252901-535A4880-47BC-444A-8496-099561DE1858Q42362493-CE3199CC-41BC-47A0-B78A-49918CDBC9AEQ47211731-D8DBA064-3F96-43D4-A9E0-FE74A64F4ED6Q47558110-DB2AA600-791C-4363-B532-797B3CDAE39AQ47787087-56526833-DE08-4504-BB18-B3A95E2350FDQ47977322-0A710BC8-BB7F-454E-A84B-F0B124289347Q48374524-59059D82-4C3D-4A6A-8BCF-6D40DD9F852DQ49616730-FC5C6B96-6DD2-4050-B9C6-92FAF8657796Q50191433-10DC0EBA-57BC-422F-AB2C-0C79995E22BEQ50417171-A2D13D88-3F99-43D0-A880-9CEF32CED2B2Q53593540-06657F57-37F9-48F1-9873-C31D777A1B89Q54986353-ECC5C1DF-D187-4E72-9B96-304D88EB053BQ55007045-8EBBC2CA-F5B5-4A20-BC84-477D2A0CF28CQ58559757-6A875CD9-89A7-4A69-B80A-91600C0E7DA5
P2860
A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
A microRNA 221- and 222-mediat ...... T3 in colorectal cancer cells.
@en
type
label
A microRNA 221- and 222-mediat ...... T3 in colorectal cancer cells.
@en
prefLabel
A microRNA 221- and 222-mediat ...... T3 in colorectal cancer cells.
@en
P2093
P2860
P1433
P1476
A microRNA 221- and 222-mediat ...... AT3 in colorectal cancer cells
@en
P2093
Chunyan Cheng
Cuifeng Li
Lunshan Wang
Mingliang Wang
Pengfei Chen
Sanhong Liu
Ulrich Siebenlist
P2860
P304
847-859.e11
P356
10.1053/J.GASTRO.2014.06.006
P407
P50
P577
2014-06-12T00:00:00Z